CompletedNCT02948088
Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project
Studying Tenosynovial giant cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Daiichi Sankyo
- Principal Investigator
- Global Clinical LeaderDaiichi Sankyo
- Enrollment
- 183 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2021
Study locations (15)
- David Geffen School of Medicine at UCLA, Los Angeles, California, United States
- University of California San Francisco, San Francisco, California, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- University of Texas MD Anderson Cancer Center, Houston, Texas, United States
- Medizinische Universität Graz, Graz, Austria
- CHU Nantes, Nantes, France
- Westdeutsches Tumorzentrum, Essen, Germany
- Istituto Ortopedico Rizzoli, Bologna, Italy
- Istituto Nazionale Tumori-Foundazione IRCCS, Milan, Italy
- Leiden University Medical Center, Leiden, Netherlands
- Radboud universitair medisch centrum, Nijmegen, Netherlands
- Hospital Sant Pau, Barcelona, Spain
- Hospital Universitario Virgen del Rocio, Seville, Spain
- The Royal Marsden Hospital, London, United Kingdom
- Nuffield Orthopaedic Centre, Oxford, United Kingdom
Collaborators
Optimapharm
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02948088 on ClinicalTrials.govOther trials for Tenosynovial giant cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07499362Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- RECRUITINGPHASE4NCT07315841Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor SurgeryShanghai Jiao Tong University Affiliated Sixth People's Hospital
- RECRUITINGNCT07075471Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With VimseltinibDeciphera Pharmaceuticals, LLC
- ACTIVE NOT RECRUITINGPHASE3NCT05417789Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)SynOx Therapeutics Limited
- ACTIVE NOT RECRUITINGPHASE3NCT05804045Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)Abbisko Therapeutics Co, Ltd
- ACTIVE NOT RECRUITINGPHASE3NCT05059262Study of Vimseltinib for Tenosynovial Giant Cell TumorDeciphera Pharmaceuticals, LLC
- ACTIVE NOT RECRUITINGPHASE2NCT04703322A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in JapanDaiichi Sankyo Co., Ltd.
- RECRUITINGNCT04635111A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) TreatmentDaiichi Sankyo